ONCAlert | 2018 ASCO Annual Meeting
Videos  >  

Combining CTLA-4 Agents With PD-1/PD-L1 Agents in Lung Cancer

David R. Gandara, MD
Published Online:6:21 PM, Fri August 18, 2017

David R. Gandara, MD, director, Thoracic Oncology Program, and professor, UC Davis Comprehensive Cancer Center, discusses the combination of CTLA-4 agents with PD-1 and PD-L1 agents for the treatment of lung cancer.
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.